Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ovarian Clear Cell Carcinoma
Related studies linked through entity extraction aliases.
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zimberelimab Plus Metformin for Recurrent Ovarian Clear Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Camrelizumab in Combination With Anlotinib in Subjects Advanced Ovarian Clear Cell Carcinoma
- Status
- UNKNOWN
- Phase
- NA
AMT-151 in Patients With Selected Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1
Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Asian Multicenter Prospective Study of ctDNA Sequencing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of PLX2853 in Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
- Status
- UNKNOWN
- Phase
- PHASE2
A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ENMD-2076 in Ovarian Clear Cell Cancers
- Status
- COMPLETED
- Phase
- PHASE2